BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35713556)

  • 1. Jugular vein inserted central venous catheters (CVC) and the risk of CVC-related bloodstream infections in patients with hematological malignancies.
    Schalk E; Biehl LM; Böll B
    Am J Hematol; 2022 Sep; 97(9):E336-E340. PubMed ID: 35713556
    [No Abstract]   [Full Text] [Related]  

  • 2. Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-study.
    Panse J; Tölle D; Fiegle E; Naendrup JH; Schmidt-Hieber M; Böll B; Hentrich M; Teschner D; Schalk E
    Ann Hematol; 2022 Oct; 101(10):2317-2324. PubMed ID: 35978182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis.
    Teschner D; Berisha M; Panse J; Schmitt T; Fiegle E; Naendrup JH; Neitz J; Schmidt-Hieber M; Hentrich M; Böll B; Schalk E
    Eur J Haematol; 2023 Dec; 111(6):914-921. PubMed ID: 37705250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which trial do we need? Scheduled central venous catheter removal vs. routine clinical care for prevention of central venous catheter-related bloodstream infections in patients with haematologic malignancies.
    Schalk E; Panse J
    Clin Microbiol Infect; 2023 Apr; 29(4):417-418. PubMed ID: 36639031
    [No Abstract]   [Full Text] [Related]  

  • 5. Central venous catheter-related bloodstream infections in patients with haematological malignancies during the SARS-CoV-2 pandemic.
    Schalk E; Schmitt T; Panse J; Fiegle E; Naendrup JH; Schmidt-Hieber M; Böll B; Hentrich M; Teschner D; Mougiakakos D
    Br J Haematol; 2022 Nov; 199(4):e16-e20. PubMed ID: 36017820
    [No Abstract]   [Full Text] [Related]  

  • 6. Overweight or obesity are not risk factors for central venous catheter-related bloodstream infections in patients with hematological malignancies.
    Schalk E; Hentrich M
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1953-1955. PubMed ID: 34924070
    [No Abstract]   [Full Text] [Related]  

  • 7. The insertion site is the main risk factor for central venous catheter-related complications in patients with hematologic malignancies.
    Heidenreich D; Hansen E; Kreil S; Nolte F; Jawhar M; Hecht A; Hofmann WK; Klein SA
    Am J Hematol; 2022 Mar; 97(3):303-310. PubMed ID: 34978721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of neutropenia on central venous catheter-related bloodstream infections in patients with hematological malignancies at the time of central venous catheter insertion: A matched-pair analysis.
    Tölle D; Hentrich M; Pelzer BW; Kremer P; Einhell S; Schulz S; Böll B; Panse J; Schmidt-Hieber M; Teschner D; Schalk E
    Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1204-1206. PubMed ID: 31352911
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of central line salvage for mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) management practices in patients with hematologic malignancies.
    El Boghdadly Z; Zhao Q; Koutou J; Lustberg ME; Ludwig M; Liscynesky C; Choe H
    Leuk Lymphoma; 2022 Jun; 63(6):1455-1463. PubMed ID: 35001802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perforation of the superior vena cava 5 days after insertion of a central venous catheter through the left internal jugular vein.
    Kurabe M; Watanabe T; Kohno T
    J Clin Anesth; 2016 Jun; 31():193-6. PubMed ID: 27185708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies.
    Boersma RS; Jie KS; Verbon A; van Pampus EC; Schouten HC
    Ann Oncol; 2008 Mar; 19(3):433-42. PubMed ID: 17962211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy).
    Fracchiolla NS; Todisco E; Bilancia A; Gandolfi S; Orofino N; Guidotti F; Mancini V; Marbello L; Assanelli A; Bernardi M; Santoro A; Cairoli R; Consonni D; Cortelezzi A
    Am J Hematol; 2017 Dec; 92(12):E656-E659. PubMed ID: 28891226
    [No Abstract]   [Full Text] [Related]  

  • 13. Catheter-related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy: a prospective comparison of silver-coated and uncoated catheters.
    Harter C; Salwender HJ; Bach A; Egerer G; Goldschmidt H; Ho AD
    Cancer; 2002 Jan; 94(1):245-51. PubMed ID: 11815983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of 5434 percutaneous pediatric central venous catheters inserted by anesthesiologists.
    Malbezin S; Gauss T; Smith I; Bruneau B; Mangalsuren N; Diallo T; Skhiri A; Nivoche Y; Dahmani S; Brasher C
    Paediatr Anaesth; 2013 Nov; 23(11):974-9. PubMed ID: 23659462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomic Site-Specific Complication Rates for Central Venous Catheter Insertions.
    Bell J; Goyal M; Long S; Kumar A; Friedrich J; Garfinkel J; Chung S; Fitzgibbons S
    J Intensive Care Med; 2020 Sep; 35(9):869-874. PubMed ID: 30231668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcomes of central venous catheters in patients with solid and hematologic neoplasms: an Italian real-world analysis.
    Corti F; Brambilla M; Manglaviti S; Di Vico L; Pisanu MN; Facchinetti C; Dotti KF; Lanocita R; Marchianò A; de Braud F; Ferrari LAM
    Tumori; 2021 Feb; 107(1):17-25. PubMed ID: 32529962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous catheters.
    Östlund Å; Fläring U; Norberg Å; Dahlberg A; Berner J; Kaiser S; Vermin L; Svenningsson A; Frisk T; Larsson P; Andersson A
    Br J Anaesth; 2019 Sep; 123(3):316-324. PubMed ID: 31176448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of central venous catheter-related bloodstream infections (CRBSIs) in patients with haematologic malignancies using a modified Infection Probability Score (mIPS).
    Schalk E; Hanus L; Färber J; Fischer T; Heidel FH
    Ann Hematol; 2015 Sep; 94(9):1451-6. PubMed ID: 25933677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative Echocardiography to Confirm Correct Central Venous Catheter Placement: A Case Report.
    Gharde P; Sarkar S; Irpachi K; Bhoje AK; Kaur B; Chauhan S
    A A Pract; 2020 Aug; 14(10):e01291. PubMed ID: 32845103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy.
    Rixecker T; Lesan V; Ahlgrimm M; Thurner L; Bewarder M; Murawski N; Christofyllakis K; Altmeyer S; Bick A; Stilgenbauer S; Bittenbring JT; Kaddu-Mulindwa D
    Bone Marrow Transplant; 2021 Jan; 56(1):195-201. PubMed ID: 32704092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.